1,196 results on '"Parving, H H"'
Search Results
202. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients
203. PO22-724 IMPACT OF METFORMIN VERSUS REPAGLINIDE ON POSTPRANDIAL GLYCAEMIA AND PLASMA LIPOPROTEINS IN NON-OBESE PATIENTS WITH TYPE-2 DIABETES MELLITUS (T2DM)
204. Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects
205. Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy
206. Aldosterone synthase (CYP11B2)344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy
207. Tu-W19:4 Impact of metformin versus repaglinide on glycemic regulation and non-glycemic cardiovascular risk-markers in non-obese patients with type-2 diabetes
208. The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy
209. Dual Blockade of the Renin-angiotensin-aldosterone System in Diabetic Nephropathy: The Role of Aldosterone
210. Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
211. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy
212. Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
213. Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria: Response to Kaiser, Florack, and Sawicki
214. ACE Insertion/Deletion Genotypes and Angiotensin II Receptor Blockade in Diabetic Nephropathy: Is there a light at the end of the tunnel?
215. Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy
216. Preventing diabetic nephropathy: an audit
217. Therapeutic Benefits of ACE Inhibitors and Other Antihypertensive Drugs in Patients With Type 2 Diabetes
218. Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuria.
219. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
220. Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
221. MULTIFACTORIAL INTERVENTION AND CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES
222. Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy.
223. CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients.
224. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes
225. Hyperglycaemia enhances renal magnesium excretion in Type 1 diabetic patients
226. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
227. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
228. Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects
229. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria
230. Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy
231. Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy
232. Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
233. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
234. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy
235. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
236. Diabetes and Risk of Adverse Events With Calcium Antagonists
237. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.
238. Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of51Cr-EDTA
239. Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients
240. Left Ventricular Hypertrophy in Non-insulin-dependent Diabetic Patients With and Without Diabetic Nephropathy
241. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study
242. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment
243. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy
244. Increased Plasma Apolipoprotein(a) Levels in IDDM Patients With Diabetic Nephropathy
245. Genetics of diabetic nephropathy.
246. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
247. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study
248. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened—a reversal in policy
249. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy
250. Author's reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.